« Back to Directory of Resources
Treatments Under Development
Here you will find a list of current treatments under development:
| Brand Name: | |
| Generic Name: | |
| Code Name: | AT9283 |
| Company: | Astex |
| FDA Clinical Phase: | 2 |
Description:
AT9283 is a kinase inhibitor that prevents cell division, thereby stopping …
| Brand Name: | |
| Generic Name: | pomalidomide |
| Code Name: | CC-4047, Actimid |
| Company: | Celgene |
| FDA Clinical Phase: | 1/2 |
Description:
Pomalidomide (new articles, forum discussions) is an immunomodulatory agent (a drug that affects the immune system) that encourages a patient’s immune system to attack and destroy myeloma cells.| Brand Name: | Atiprimod |
| Generic Name: | azaspirane |
| Code Name: | SK&F106615 |
| Company: | Callisto Pharmaceuticals |
| FDA Clinical Phase: | 1/2 |
Description:
Atiprimod is a type of signal transduction inhibitor. It is being studied in the treatment of certain multiple myelomas and| Brand Name: | Avastin |
| Generic Name: | bevacizumab |
| Code Name: | rhuMAb-VEGF |
| Company: | Genentech Inc. |
| FDA Clinical Phase: | 1/2 |
Description:
Avastin is a monoclonal antibody used in the treatment of colorectal cancer that has spread. It is also| Brand Name: | Treanda |
| Generic Name: | bendamustine |
| Code Name: | SDX-105 |
| Company: | Cephalon Oncology |
| FDA Clinical Phase: | 1/2 |
Description:
Treanda (news articles) is a drug that is …
| Brand Name: | |
| Generic Name: | |
| Code Name: | CEP-18770 |
| Company: | Cephalon |
| FDA Clinical Phase: | 1/2 |
Description:
CEP-18770 is a boronic-acid based proteasome inhibitor that suppresses tumor growth by inhibiting the enzymes that break down important proteins in cancerous cells. Animal studies showed that …
